Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy
Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech (OTCPK:SGBCF) to jointly develop and market a biosimilar version of Darzalex, a multiple ...
New program launches to train NJ community college students for gene therapy jobs
Johnson & Johnson is contributing $1 million to support the development of curricula and modernization of training and lab ...
usace.army.mil2d
Preventive Medicine Food Sanitation Inspectors Keeping Fort Johnson Healthy
Have you ever wondered what the letter grades mean that are posted outside dining facilities, food trucks, concessions, ...